Xing D - Search Results

1

Recent advances in bacteria-mediated cancer therapy.

Liang S, Wang C, Shao Y, Wang Y, Xing D, Geng Z. Liang S, et al. Among authors: xing d. Front Bioeng Biotechnol. 2022 Oct 12;10:1026248. doi: 10.3389/fbioe.2022.1026248. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36312554 Free PMC article. Review.

2

Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection.

Chen W, Liang B, Wu X, Li L, Wang C, Xing D. Chen W, et al. Among authors: xing d. J Pharm Anal. 2023 Mar;13(3):255-261. doi: 10.1016/j.jpha.2022.10.005. Epub 2022 Nov 2. J Pharm Anal. 2023. PMID: 36345404 Free PMC article. Review.

3

Advances in antitumor research of CA-4 analogs carrying quinoline scaffold.

Wang C, Chang J, Yang S, Shi L, Zhang Y, Liu W, Meng J, Zeng J, Zhang R, Xing D. Wang C, et al. Among authors: xing d. Front Chem. 2022 Oct 28;10:1040333. doi: 10.3389/fchem.2022.1040333. eCollection 2022. Front Chem. 2022. PMID: 36385996 Free PMC article. Review.

4

ALT-803 in the treatment of non-muscle-invasive bladder cancer: Preclinical and clinical evidence and translational potential.

Chen W, Liu N, Yuan Y, Zhu M, Hu X, Hu W, Wang S, Wang C, Huang B, Xing D. Chen W, et al. Among authors: xing d. Front Immunol. 2022 Nov 10;13:1040669. doi: 10.3389/fimmu.2022.1040669. eCollection 2022. Front Immunol. 2022. PMID: 36439125 Free PMC article. Review.

5

New insights into bacterial mechanisms and potential intestinal epithelial cell therapeutic targets of inflammatory bowel disease.

Liang B, Wu C, Wang C, Sun W, Chen W, Hu X, Liu N, Xing D. Liang B, et al. Among authors: xing d. Front Microbiol. 2022 Dec 16;13:1065608. doi: 10.3389/fmicb.2022.1065608. eCollection 2022. Front Microbiol. 2022. PMID: 36590401 Free PMC article. Review.

6

Developments of PROTACs technology in immune-related diseases.

Wang C, Zhang Y, Deng J, Liang B, Xing D. Wang C, et al. Among authors: xing d. Eur J Med Chem. 2023 Mar 5;249:115127. doi: 10.1016/j.ejmech.2023.115127. Epub 2023 Jan 20. Eur J Med Chem. 2023. PMID: 36724631 Review.

7

The research progress on the anxiolytic effect of plant-derived flavonoids by regulating neurotransmitters.

Wang C, Yang S, Deng J, Shi L, Chang J, Meng J, Liu W, Zeng J, Xing K, Wen J, Liang B, Xing D. Wang C, et al. Among authors: xing k, xing d. Drug Dev Res. 2023 May;84(3):458-469. doi: 10.1002/ddr.22038. Epub 2023 Feb 6. Drug Dev Res. 2023. PMID: 36744648 Review.

8

Corrigendum to "Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer" [Pharmacology & Therapeutics 239 (2022) 108296].

Liu X, Deng J, Yuan Y, Chen W, Sun W, Wang Y, Huang H, Liang B, Ming T, Wen J, Huang B, Xing D. Liu X, et al. Among authors: xing d. Pharmacol Ther. 2023 Mar;243:108336. doi: 10.1016/j.pharmthera.2022.108336. Epub 2023 Feb 15. Pharmacol Ther. 2023. PMID: 36804040 No abstract available.

9

MST1: A future novel target for cardiac diseases.

Shao Y, Wang Y, Sun L, Zhou S, Xu J, Xing D. Shao Y, et al. Among authors: xing d. Int J Biol Macromol. 2023 Jun 1;239:124296. doi: 10.1016/j.ijbiomac.2023.124296. Epub 2023 Apr 1. Int J Biol Macromol. 2023. PMID: 37011743 Review.

10

Marine Sulfated Polysaccharide PMGS Synergizes with Paclitaxel in Inhibiting Cervical Cancer In Vitro.

Xia X, Wang Y, Shao Y, Xu J, Liang B, Liu W, Zeng J, Li C, Guan H, Wang S, Xing D. Xia X, et al. Among authors: xing d. Mar Drugs. 2023 Apr 23;21(5):259. doi: 10.3390/md21050259. Mar Drugs. 2023. PMID: 37233453 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,028 results

Search Page